ArticleToxicological research2025
In vitro study of silver nanoparticles-induced embryotoxicity using a rat whole embryo culture model.
Article in Toxicological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mechanistic paradigms of teratogenicity induced by metallic nanoparticles-a mini review.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026Review
- Microbial-Based Green Synthesis of Silver Nanoparticles: A Comparative Review of Bacteria- and Fungi-Mediated Approaches.International journal of molecular sciences · 2025Review
- Polymeric Systems as Hydrogels and Membranes Containing Silver Nanoparticles for Biomedical and Food Applications: Recent Approaches and Perspectives.Gels (Basel, Switzerland) · 2025Review
- Silver Nanoparticle-Induced Nephrotoxicity in Zebrafish (International journal of molecular sciences · 2025Article
- Green Synthesis of Silver Nanoparticles fromMolecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, our in vivo experiment showed that silver nanoparticles (AgNPs) did not cause developmental toxicity. However, the putative influences of direct exposure of AgNPs on the embryo-fetuses could not be elucidated because the embryo-fetus was exposed to AgNPs through their dams. In this study, the potential impact of AgNPs on embryonic development during the critical phase of organogenesis was examined utilizing a rat whole embryo culture model. This system could separate the direct effects of AgNPs from those that are maternally mediated. To evaluate the embryotoxic potential of AgNPs, embryos were exposed to 1.67, 5, and 15 μg/mL of AgNPs for 48 h. At the conclusion of the culture period, embryonic growth and development were assessed, and morphological abnormalities were systematically evaluated. Also, apoptosis induced by AgNPs was evaluated by TUNEL and immunohistochemistry for caspase-3. At 15 μg/mL, a retardation in embryonic growth and differentiation, accompanied by a heightened frequency of morphological abnormalities, including abnormal axial rotation, open neural tube, absent optic vesicle, and growth retarded were observed in a dose-dependent manner. At this concentration, caspase-3-positive cells appeared in the treated embryonic tissues compared to controls. At 5 μg/mL, AgNPs also caused a decrease in the embryonic otic system, somite number, and total morphological score. No adverse effects on embryonic growth and development associated with the treatment were observed at 1.67 μg/mL. The findings demonstrated that the direct exposure of AgNPs to rat embryos induces developmental delays and morphological abnormalities, and that AgNPs can induce a direct developmental toxicity and caspase-dependent apoptosis in rat embryos.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.